This is one tough subject by all means. Yes, consumers want early access, but on the other hand if there’s not enough information regarding issues such as side effects, a drug could in fact hasten the process with individuals dying sooner, again studies are what is needed to be safe. ...
Posted to
The Medical Quack .... by Barbara Duck
on 07-07-2008
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, Cancer, FDA, clinical trials, Research, University of California